Korro Bio
KRRO
58 hedge funds and large institutions have $13M invested in Korro Bio in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 34 closing their positions.
0.41% less ownership
Funds ownership: 0.91% → 0.5% (-0.41%)
32% less funds holding
Funds holding: 85 → 58 (-27)
52% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 21
66% less capital invested
Capital invested by funds: $38.1M → $13M (-$25.1M)
71% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 34
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$714K |
| 2 |
Renaissance Technologies
New York
|
+$450K |
| 3 |
Millennium Management
New York
|
+$276K |
| 4 |
E
Ergoteles
New York
|
+$211K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$166K |
Top Sellers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$4.96M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.22M |
| 3 |
BlackRock
New York
|
-$2.11M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.91M |
| 5 |
JP Morgan Chase
New York
|
-$1.42M |
KRRO Hedge Fund Activity: Q2 2022 in Review
58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2022, worth a combined $13M — down 66% from $38.1M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of KRRO and 10 opened new positions — a net loss of 24 holders — while 21 trimmed existing stakes and 10 added.
The largest buyer was Vanguard Group, adding an estimated $714K. The largest seller was Nuveen, exiting entirely with an estimated $4.96M sold.
- 58 institutional investors held Korro Bio (KRRO) as of Q2 2022, down from 85 in Q1 2022.
- Funds reported $13M of Korro Bio stock for Q2 2022, down 66% quarter-over-quarter.
- 10 funds opened new Korro Bio positions in Q2 2022 and 34 closed out, a net change of -24 holders.
- The largest Korro Bio buyer in Q2 2022 was Vanguard Group, an estimated $714K added.
- The largest Korro Bio seller in Q2 2022 was Nuveen, an estimated $4.96M sold.
Based on aggregated 13F filings for Q2 2022.